Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Jun 28, 2021 12:57pm
236 Views
Post# 33460096

RE:More good news

RE:More good news

GoBig2000 wrote: Fantastic to have a testimonial from a patient. We have been hearing about ongoing negotiations for months. Give us any type of deal or at least a NASDAQ listing???

 


We have been hearing about a deal for over ten years now. Don't hold your breath . Nasdaq? Toleikis kisssed that goodbye by doing an awful bot deal that killed the share price and momentum .

You need active revenue or income plus $3 share US to qualify for Nasdaq. Toleikis can barely do the IR and answer retail phone calls while reading the blog and taking advice from Matthews and Hollar all day.  There has to be a catalyst to get so moving and there will be nothing until next year. 


Only time mangement pretends to listen to shareholders is when then need votes for AGM or need financing .  Maybe your so called scientists can tell you that .

Ms Sally 

<< Previous
Bullboard Posts
Next >>